Membership set to exceed expectations with at least 800,000 new enrollees
- CVS Health Corp. expects its 2024 Medicare Advantage enrollment to exceed expectations
- Membership set to grow by at least 800,000
- Higher proportion of new sales coming from competitor Medicare Advantage plans
- CVS is one of the largest Medicare Advantage insurers with about 11% of total enrollment in 2023
- Reaffirms full-year 2023 earnings guidance and expects adjusted earnings per share to be in the top half of its guidance range
- Reiterates previous earnings guidance of at least $7.26 per share for full year 2024
- CVS shares gained 0.1% premarket on Friday
CVS Health Corp. announced that its 2024 Medicare Advantage enrollment is beating expectations, with membership projected to grow by at least 800,000. The company reported that both individual Medicare Advantage and dual-eligible special needs enrollment surpassed anticipated levels during the annual enrollment period. This growth was driven, in part, by a higher proportion of new sales coming from competitor Medicare Advantage plans. As one of the largest Medicare Advantage insurers, CVS currently holds approximately 11% of total enrollment in 2023. The company also reaffirmed its full-year 2023 earnings guidance and expects adjusted earnings per share to be in the top half of its guidance range. For the full year 2024, CVS reiterated its previous earnings guidance of at least $7.26 per share. CVS shares gained 0.1% premarket on Friday.
Public Companies: CVS Health Corp. (CVS)
Private Companies:
Key People:
Factuality Level: 8
Justification: The article provides specific information about CVS Health Corp’s Medicare Advantage enrollment, including the growth in membership and the reasons behind it. It also includes information about the company’s earnings guidance. The information provided is based on a regulatory filing and includes data from a health policy research nonprofit. However, the article does not provide any opposing viewpoints or independent analysis, which could affect the overall factuality level.
Noise Level: 7
Justification: The article provides information about CVS Health Corp’s Medicare Advantage enrollment exceeding expectations and its earnings guidance. However, it lacks in-depth analysis, evidence, and actionable insights. It stays on topic but does not explore the consequences of decisions or hold powerful people accountable.
Financial Relevance: Yes
Financial Markets Impacted: Medicare Advantage insurers
Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article pertains to CVS Health Corp’s Medicare Advantage enrollment, which is relevant to financial markets. There is no mention of an extreme event.
www.marketwatch.com 
